Cargando…

Correction: Comparison of SGLT2 inhibitors with DPP4 inhibitors combined with metformin in patients with acute myocardial infarction and diabetes mellitus

Detalles Bibliográficos
Autores principales: Lyu, Young Sang, Oh, Seok, Kim, Jin Hwa, Kim, Sang Yong, Jeong, Myung Ho
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10478380/
https://www.ncbi.nlm.nih.gov/pubmed/37670278
http://dx.doi.org/10.1186/s12933-023-01960-y
_version_ 1785101336966070272
author Lyu, Young Sang
Oh, Seok
Kim, Jin Hwa
Kim, Sang Yong
Jeong, Myung Ho
author_facet Lyu, Young Sang
Oh, Seok
Kim, Jin Hwa
Kim, Sang Yong
Jeong, Myung Ho
author_sort Lyu, Young Sang
collection PubMed
description
format Online
Article
Text
id pubmed-10478380
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-104783802023-09-06 Correction: Comparison of SGLT2 inhibitors with DPP4 inhibitors combined with metformin in patients with acute myocardial infarction and diabetes mellitus Lyu, Young Sang Oh, Seok Kim, Jin Hwa Kim, Sang Yong Jeong, Myung Ho Cardiovasc Diabetol Correction BioMed Central 2023-09-05 /pmc/articles/PMC10478380/ /pubmed/37670278 http://dx.doi.org/10.1186/s12933-023-01960-y Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Correction
Lyu, Young Sang
Oh, Seok
Kim, Jin Hwa
Kim, Sang Yong
Jeong, Myung Ho
Correction: Comparison of SGLT2 inhibitors with DPP4 inhibitors combined with metformin in patients with acute myocardial infarction and diabetes mellitus
title Correction: Comparison of SGLT2 inhibitors with DPP4 inhibitors combined with metformin in patients with acute myocardial infarction and diabetes mellitus
title_full Correction: Comparison of SGLT2 inhibitors with DPP4 inhibitors combined with metformin in patients with acute myocardial infarction and diabetes mellitus
title_fullStr Correction: Comparison of SGLT2 inhibitors with DPP4 inhibitors combined with metformin in patients with acute myocardial infarction and diabetes mellitus
title_full_unstemmed Correction: Comparison of SGLT2 inhibitors with DPP4 inhibitors combined with metformin in patients with acute myocardial infarction and diabetes mellitus
title_short Correction: Comparison of SGLT2 inhibitors with DPP4 inhibitors combined with metformin in patients with acute myocardial infarction and diabetes mellitus
title_sort correction: comparison of sglt2 inhibitors with dpp4 inhibitors combined with metformin in patients with acute myocardial infarction and diabetes mellitus
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10478380/
https://www.ncbi.nlm.nih.gov/pubmed/37670278
http://dx.doi.org/10.1186/s12933-023-01960-y
work_keys_str_mv AT lyuyoungsang correctioncomparisonofsglt2inhibitorswithdpp4inhibitorscombinedwithmetformininpatientswithacutemyocardialinfarctionanddiabetesmellitus
AT ohseok correctioncomparisonofsglt2inhibitorswithdpp4inhibitorscombinedwithmetformininpatientswithacutemyocardialinfarctionanddiabetesmellitus
AT kimjinhwa correctioncomparisonofsglt2inhibitorswithdpp4inhibitorscombinedwithmetformininpatientswithacutemyocardialinfarctionanddiabetesmellitus
AT kimsangyong correctioncomparisonofsglt2inhibitorswithdpp4inhibitorscombinedwithmetformininpatientswithacutemyocardialinfarctionanddiabetesmellitus
AT jeongmyungho correctioncomparisonofsglt2inhibitorswithdpp4inhibitorscombinedwithmetformininpatientswithacutemyocardialinfarctionanddiabetesmellitus